Mirae Asset Global Investments Co., Ltd.

Position in KNSA — Kiniksa Pharmaceuticals International, plc

CIK 1569395 SEOUL, M5

Back to KNSA Full portfolio

Position in KNSA

as of Mar 31, 2026 · filed May 4, 2026 Compact

Position Value

$692,637

+$107,465 QoQ

Shares Held

14,385

+1.4% QoQ

Ownership

0.009%

of shares outstanding

% of Portfolio

0.00%

of 13F equity value

Holder Rank

—

not a current holder

Holding Since

Jun 2024

8 quarters on record

Voting authority Sole 100% Shared 0% None 0%

Common Shares in KNSA Over Time

Shares Held

Position Value (USD)

Position in Drug Manufacturers - Specialty & Generic

Healthcare · as of Mar 31, 2026

Mirae Asset Global Investments Co., Ltd. holds $22,631,351 across 30 Drug Manufacturers - Specialty & Generic names. KNSA ranks #5 (3.1% of the industry book) .

#	Ticker	Company	Shares	Value (USD)
1	ZTS	Zoetis Inc.	94,998	$11,229,712
2	VTRS	Viatris Inc	283,050	$3,824,005
3	UTHR	UNITED THERAPEUTICS Corp	4,828	$2,862,907
4	NBIX	Neurocrine Biosciences Inc	10,408	$1,371,149
5	KNSA	Kiniksa Pharmaceuticals International, plc This page	14,385	$692,637
6	ELAN	Elanco Animal Health Inc	21,502	$514,542
7	INDV	Indivior Pharmaceuticals, Inc.	14,503	$442,051
8	ALKS	Alkermes plc.	8,692	$307,349

All Filings in KNSA

Export CSV

8 filing rows on record

Report Date	Value (USD)	Shares	Change	Type	Discretion	Filed
2026-03-31	$692,637	14,385	+1.4%	Shares	Sole	2026-05-04
2025-12-31	$585,172	14,186	+21.2%	Shares	Sole	2026-01-26
2025-09-30	$454,349	11,701	+615.7%	Shares	Sole	2025-11-03
2025-06-30	$45,240	1,635	+12.8%	Shares	Sole	2025-07-21
2025-03-31	$32,204	1,450	+4.7%	Shares	Sole	2025-04-24
2024-12-31	$27,395	1,385	-5.7%	Shares	Sole	2025-01-27
2024-09-30	$36,710	1,469	+22.1%	Shares	Sole	2024-10-23
2024-06-30	$22,460	1,203	—	Shares	Sole	2024-07-30
No filing history on record for this holder in this stock.